Average Co-Inventor Count = 4.80
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurogen Corporation (10 from 305 patents)
2. Other (6 from 832,680 patents)
3. Rib-x Pharmaceuticals, Inc. (3 from 17 patents)
4. Pfizer Corporation (1 from 4,455 patents)
5. Melinta Therapeutics, Inc. (1 from 23 patents)
20 patents:
1. 9550783 - Biaryl heterocyclic compounds and methods of making and using the same
2. 7705026 - Biaryl heterocyclic compounds and methods of making and using the same
3. 7456206 - Biaryl heterocyclic compounds and methods of making and using the same
4. 7148219 - Biaryl heterocyclic compounds and methods of making and using the same
5. 7074929 - Certain alkylene diamine-substituted heterocycles
6. 6969726 - Biaryl heterocyclic compounds and methods of making and using the same
7. 6696445 - Certain alkylene diamine-substituted heterocycles
8. 6566367 - Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
9. 6544996 - 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
10. 6506762 - Certain alkylene diamine-substituted heterocycles
11. 6486164 - 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
12. 6476038 - Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
13. 6444819 - Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
14. 6372743 - Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
15. 6333329 - 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands